HOOKIPA Pharma Appoints Mark Winderlich as Chief Development Officer to Lead Clinical Research and Development Organization -January 16, 2024 at 07:02 am EST
NEW YORK and VIENNA, Austria, Jan. 16, 2024 -- HOOKIPA Pharma Inc. , a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced the...
Source: marketscreener.com